Andere talen Universe Pharmaceuticals INC

Aandelen

UPC

KYG9442G1120

Beurs gesloten - Nasdaq Andere beurzen 22:30:01 16-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,51 ^USD	-2,71%		+16,74%	+24,88%

30/01	Universe Pharmaceuticals INC rapporteert resultaten voor het volledige jaar eindigend op 30 september 2023	CI
2023	Top stijgers op de premarket	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Top Premarket Decliners	15/04
Universe Pharmaceuticals INC Reports Fiscal Year 2023 Financial Results	30/01
Universe Pharmaceuticals INC Reports Earnings Results for the Full Year Ended September 30, 2023	30/01
Top Premarket Gainers	11-09-23
Universe Pharmaceuticals INC Reports Earnings Results for the Half Year Ended March 31, 2023	31-08-23
Universe Pharmaceuticals : Receipt of Nasdaq Notification Regarding Compliance with Nasdaq Minimum Bid Price Requirement - Form 6-K	16-08-23
Universe Pharmaceuticals Receives Nasdaq Non-Compliance Notice	04-08-23
Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares	04-08-23
Universe Pharmaceuticals INC Announces Share Consolidation	27-07-23
Universe Pharmaceuticals : Results of the Universe Pharmaceuticals INC 2023 Annual General Meeting - Form 6-K	05-07-23
Universe Pharmaceuticals INC Announces Board Changes	05-05-23
Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency	07-03-23
Universe Pharmaceuticals INC Reports Earnings Results for the Full Year Ended September 30, 2022	10-02-23
Universe Pharmaceuticals INC Announces Inclusion of Six Products into the First Edition of Catalogue of Medicine for Patients Infected with COVID-19	21-12-22
Universe Pharmaceuticals INC Announces Inclusion of Six Products into the First Edition of Catalogue of Medicine for Patients Infected with COVID-19	21-12-22
Universe Pharmaceuticals INC Regains Compliance with Nasdaq Minimum Bid Price Requirement	14-11-22
Universe Pharmaceuticals INC Regains Compliance with Nasdaq Minimum Bid Price Requirement	14-11-22
Universe Pharmaceuticals : Results of the Universe Pharmaceuticals INC 2022 Annual General Meeting - Form 6-K	28-09-22
Universe Pharmaceuticals INC Reports Earnings Results for the Half Year Ended March 31, 2022	16-08-22
Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2022	16-08-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Universe Pharmaceuticals INC

Aandelen

UPC

KYG9442G1120

Andere talen

Filters